161
Preventive AMD Treatments
2335.
27. Moeller SM, Parekh N, Tinker L, Ritenbaugh C, Blodi B, Wal-
lace RB, Mares JA. Associations between intermediate age-related
macular degeneration and lutein and zeaxanthin in the Carote-
noids in Age-related Eye Disease Study (CAREDS): ancillary
study of the Women’s Health Initiative. Arch Ophthalmol 2006;
124 (8): 1151-1162.
28. SanGiovanni JP, Chew EY, Clemons TE, Ferris FL, III, Gensler
G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD. The rela-
tionship of dietary carotenoid and vitamin A, E, and C intake with
age-related macular degeneration in a case-control study: AREDS
Report No. 22. Arch Ophthalmol 2007; 125 (9): 1225-1232.
29. Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary
supplementation on contrast sensitivity in age-related macular
disease: a randomized controlled trial. Eur J Clin Nutr 2007; 61
(9): 1121-1127.
30. Massacesi AL, Faletra R, Gerosa F, Staurenghi G, Orzalesi N.
The effect of oral supplementation of macular carotenoids (lutein
and zeaxanthin) on the prevention of age-related macular degen-
eration: A 18 months follow up study. ARVO. Fort Lauderdale,
USA, April 29-May 4, 2001. Invest Ophthalmol Vis Sci 2001;
42 (4 Suppl.): S234.
31. Olmedilla B, Granado F, Blanco I, Vaquero M, Cajigal C. Lutein
in patients with cataracts and age-related macular degeneration :
a long-term supplementation study. J Sci Food Agric 2001; 81
(9): 904-909.
32. Richer S. Part II: ARMD--pilot (case series) environmental inter-
vention data. J Am Optom Assoc 1999; 70 (1): 24-36.
33. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Di-
etary antioxidants and primary prevention of age related macular
degeneration: systematic review and meta-analysis. BMJ 2007;
335 (7623): 755.
34. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D,
Pei K, Tsipursky M, Nyland J. Double-masked, placebo-control-
led, randomized trial of lutein and antioxidant supplementation
in the intervention of atrophic age-related macular degeneration:
the Veterans LAST study (Lutein Antioxidant Supplementation
Trial). Optometry 2004; 75 (4): 216-230.
35. Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R,
Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in
age-related maculopathy: design and methods. Ophthalmic Epi-
demiol 2008; 15 (6): 389-401.
36. Seddon JM, Hennekens CH. Vitamins, minerals, and macular
degeneration. Promising but unproven hypotheses. Arch Oph-
thalmol 1994; 112 (2): 176-179.
37. Antioxidant status and neovascular age-related macular degenera-
tion. Eye Disease Case-Control Study Group. Arch Ophthalmol
1993; 111 (1): 104-109. Erratum in: Arch Ophthalmol 1993;
111 (11): 1499. Arch Ophthalmol 1993; 111 (9): 1228. Arch
Ophthalmol 1993; 111 (10): 1366
38. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S,
Bressler NM. Are antioxidants or supplements protective for age-
related macular degeneration? Arch Ophthalmol 1994; 112 (2):
222-227.
39. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE,
Brady WE, Palta M. Associations between antioxidant and zinc in-
take and the 5-year incidence of early age-related maculopathy in the
Beaver Dam Eye Study. Am J Epidemiol 1998; 148 (2): 204-214.
40. A randomized, placebo-controlled, clinical trial of high-dose sup-
plementation with vitamins C and E, beta carotene, and zinc for
age-related macular degeneration and vision loss: AREDS Report
No. 8. Arch Ophthalmol 2001; 119 (10): 1417-1436. Erratum
in: 2008; 126 (9): 1251.
41. Clemons TE, Kurinij N, Sperduto RD. Associations of mortality
with ocular disorders and an intervention of high-dose antioxidants
and zinc in the Age-Related Eye Disease Study: AREDS Report No.
13. Arch Ophthalmol 2004; 122 (5): 716-726.
42. Van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC,
Klaver CC, Hofman A, de Jong PT. Dietary intake of antioxi-
dants and risk of age-related macular degeneration. JAMA 2005;
294 (24): 3101-3107.
43. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Di-
etary antioxidants and primary prevention of age related macular
degeneration: systematic review and meta-analysis. BMJ 2007;
335 (7623): 755.
44. Evans J. Antioxidant supplements to prevent or slow down the
progression of AMD: a systematic review and meta-analysis. Eye
(Lond) 2008; 22 (6): 751-760.
45. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon
JM, Colditz GA, Hankinson SE. Prospective study of dietary fat
and the risk of age-related macular degeneration. Am J Clin Nutr
2001; 73 (2): 209-218.
46. Arnarsson A, Sverrisson T, Stefansson E, Sigurdsson H, Sasaki
H, Sasaki K, Jonasson F. Risk factors for five-year incident age-
related macular degeneration: the Reykjavik Eye Study. Am J
Ophthalmol 2006; 142 (3): 419-428.
47. Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P.
Dietary fatty acids and the 5-year incidence of age-related macu-
lopathy. Arch Ophthalmol 2006; 124 (7): 981-986.
48. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA,
Blair NP, Willett W. Dietary fat and risk for advanced age-related
macular degeneration. Arch Ophthalmol 2001; 119 (8): 1191-
1199.
49. Seddon JM, George S, Rosner B. Cigarette smoking, fish consump-
tion, omega-3 fatty acid intake, and associations with age-related
macular degeneration: the US Twin Study of Age-Related Macular
Degeneration. Arch Ophthalmol 2006; 124 (7): 995-1001.
50. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL,
III, Gensler GR, Kurinij N, Lindblad AS, Milton RC, Seddon
JM, Sperduto RD. The relationship of dietary lipid intake and
age-related macular degeneration in a case-control study: AREDS
Report No. 20. Arch Ophthalmol 2007; 125 (5): 671-679.
51. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg
GM, Klein BE, Palta M. Dietary fat and age-related maculopa-
thy. Arch Ophthalmol 1995; 113 (6): 743-748.
52. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA,
Blair NP, Willett W. Dietary fat and risk for advanced age-related
macular degeneration. Arch Ophthalmol 2001; 119 (8): 1191-
1199.
